S&P 500
(0.32%) 5 116.17 points
Dow Jones
(0.38%) 38 386 points
Nasdaq
(0.35%) 15 983 points
Oil
(-1.36%) $82.71
Gas
(6.71%) $2.05
Gold
(0.05%) $2 348.30
Silver
(-0.35%) $27.44
Platinum
(4.08%) $959.75
USD/EUR
(-0.23%) $0.933
USD/NOK
(0.09%) $11.03
USD/GBP
(-0.55%) $0.796
USD/RUB
(1.55%) $93.30

Actualizaciones en tiempo real para Sihuan Pharmaceutical [0460.HK]

Bolsa: HKSE Industria: Drug Manufacturers
Última actualización29 abr 2024 @ 04:08

0.00% HKD 0.560

Live Chart Being Loaded With Signals

Commentary (29 abr 2024 @ 04:08):

Sihuan Pharmaceutical Holdings Group Ltd., an investment holding company, engages in the research and development, manufacture, marketing, and sale of pharmaceutical products in the People's Republic of China...

Stats
Volumen de hoy 16.35M
Volumen promedio 7.60M
Capitalización de mercado 5.20B
EPS HKD0 ( 2024-03-27 )
Last Dividend HKD0.0370 ( 2023-06-06 )
Next Dividend HKD0 ( N/A )
P/E -56.00
ATR14 HKD0.00100 (0.18%)

Volumen Correlación

Largo: 0.02 (neutral)
Corto: 0.00 (neutral)
Signal:(36.365) Neutral

Sihuan Pharmaceutical Correlación

10 Correlaciones Más Positivas
10 Correlaciones Más Negativas

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Sihuan Pharmaceutical Correlación - Moneda/Commodity

The country flag 0.57
( weak )
The country flag 0.27
( neutral )
The country flag 0.00
( neutral )
The country flag 0.00
( neutral )
The country flag 0.00
( neutral )
The country flag -0.55
( weak negative )

Sihuan Pharmaceutical Finanzas

Annual 2023
Ingresos: HKD1.86B
Beneficio Bruto: HKD1.30B (69.64 %)
EPS: HKD-0.00580
FY 2023
Ingresos: HKD1.86B
Beneficio Bruto: HKD1.30B (69.64 %)
EPS: HKD-0.00580
FY 2022
Ingresos: HKD2.18B
Beneficio Bruto: HKD1.49B (68.20 %)
EPS: HKD-0.210
FY 2021
Ingresos: HKD3.29B
Beneficio Bruto: HKD2.45B (74.39 %)
EPS: HKD0.0440

Financial Reports:

No articles found.

Sihuan Pharmaceutical Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
HKD0.0360
(N/A)
HKD0
(N/A)
HKD0
(N/A)
HKD0.0370
(N/A)
HKD0
(N/A)
HKD0
(N/A)
HKD0
(N/A)
HKD0
(N/A)
HKD0
(N/A)
HKD0
(N/A)

Sihuan Pharmaceutical Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 3.27 - low (8.85%) | Divividend Growth Potential Score: 0 - No dividend expected

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information
First Dividend HKD0.0390 2011-09-21
Last Dividend HKD0.0370 2023-06-06
Next Dividend HKD0 N/A
Payout Date 0000-00-00
Next Payout Date N/A
# dividends 23 --
Total Paid Out HKD0.764 --
Avg. Dividend % Per Year 0.00% --
Score 1.03 --
Div. Sustainability Score 3.27
Div.Growth Potential Score 0
Div. Directional Score 0.991 --
Next Divdend (Est)
(2024-10-25)
HKD0.0364 Estimate 3.62 %
Dividend Stability
0.29 Very Poor
Dividend Score
1.03
Pay Frequency
Annually
Yearly Payout
Year Amount Yield

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for HKSE

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
6117.HK Ex Dividend Junior 2023-05-22 Sporadic 0 0.00%
1857.HK Ex Dividend Junior 2023-08-23 Semi-Annually 0 0.00%
0881.HK Ex Dividend Junior 2023-06-23 Annually 0 0.00%
0026.HK Ex Dividend Junior 2023-10-03 Semi-Annually 0 0.00%
2669.HK Ex Dividend Knight 2023-06-23 Semi-Annually 0 0.00%
1428.HK Ex Dividend Knight 2023-08-23 Annually 0 0.00%
0518.HK Ex Dividend Junior 2023-09-01 Sporadic 0 0.00%
6869.HK Ex Dividend Junior 2023-07-04 Annually 0 0.00%
1977.HK Ex Dividend Knight 2023-09-11 Semi-Annually 0 0.00%
1036.HK Ex Dividend Junior 2023-06-21 Annually 0 0.00%

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM-0.02901.500-0.581-0.871[0 - 0.5]
returnOnAssetsTTM-0.004681.200-0.156-0.187[0 - 0.3]
returnOnEquityTTM-0.01221.500-1.247-1.870[0.1 - 1]
payoutRatioTTM-5.53-1.000-10.0010.00[0 - 1]
currentRatioTTM1.5110.8007.455.96[1 - 3]
quickRatioTTM1.1600.8007.886.30[0.8 - 2.5]
cashRatioTTM0.9201.5006.009.00[0.2 - 2]
debtRatioTTM0.106-1.5008.23-10.00[0 - 0.6]
interestCoverageTTM01.000-1.111-1.111[3 - 30]
operatingCashFlowPerShareTTM0.003182.0010.0010.00[0 - 30]
freeCashFlowPerShareTTM-0.005102.00-0.00255-0.00510[0 - 20]
debtEquityRatioTTM0.277-1.5008.89-10.00[0 - 2.5]
grossProfitMarginTTM0.6961.0001.7271.727[0.2 - 0.8]
operatingProfitMarginTTM-0.07361.000-3.47-3.47[0.1 - 0.6]
cashFlowToDebtRatioTTM0.02311.000-0.983-0.983[0.2 - 2]
assetTurnoverTTM0.1610.800-2.26-1.806[0.5 - 2]
Total Score3.27

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM-85.441.000-8.730[1 - 100]
returnOnEquityTTM-0.01222.50-0.802-1.870[0.1 - 1.5]
freeCashFlowPerShareTTM-0.005102.00-0.00170-0.00510[0 - 30]
dividendYielPercentageTTM7.141.50010.000[0 - 0.4]
operatingCashFlowPerShareTTM0.003182.0010.0010.00[0 - 30]
payoutRatioTTM-5.531.500-10.0010.00[0 - 1]
pegRatioTTM-0.9341.500-9.560[0.5 - 2]
operatingCashFlowSalesRatioTTM0.01521.000-2.120[0.1 - 0.5]
Total Score-1.286

Sihuan Pharmaceutical

Sihuan Pharmaceutical Holdings Group Ltd., an investment holding company, engages in the research and development, manufacture, marketing, and sale of pharmaceutical products in the People's Republic of China. It offers drugs in the oncology, metabolic diseases, digestive system, and other therapeutic areas. The company is also involved in the investment and sale of medical beauty products; manufacture of medical instruments; investment in properties; construction for medical projects; and project preparation for pharmaceutical products manufacturing. In addition, it provides information support, general hospital, hospital management, biotechnology promotion, and medical aesthetic research and development services. The company was founded in 2001 and is based in Wanchai, Hong Kong.

Acerca de Señales en Vivo

Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.

Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico